Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholecalciferol Dosing Regimens in Vitamin D Deficiency
NCT02069990Phase 3Completed
- Sponsor
- Semmelweis University
- Start
- Mar 2013
- Primary completion
- Sep 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vitamin d in Vitamin D deficiency (VDD) (4 arms), sponsored by Semmelweis University. Primary endpoint: Serum 25-hydroxyvitamin D level at 12 weeks. Started Mar 2013; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT02069990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02069990.